SEC Form 4 · accession 0001437749-18-000121
Oxford Immunotec Global PLC · OXFD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard M. Altieri
Officer — Chief Financial Officer
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 1, 2018 | F | 778 | $13.97 | D | 52,115 | D | |
| Ordinary SharesF2 | Jan 1, 2018 | F | 1,480 | $13.97 | D | 50,635 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to pay withholding taxes upon vesting of restricted share units originally granted on June 19, 2015. The number of shares withheld was determined based on the closing price on the last prior trading day which was December 29, 2017.
- F2Represents shares withheld to pay withholding taxes upon vesting of restricted share units originally granted on March 4, 2016. The number of shares withheld was determined based on the closing price on the last prior trading day which was December 29, 2017.